Benjamin Edwards Inc’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-2,211
Closed -$346K 1327
2025
Q3
$346K Buy
+2,211
New +$351K ﹤0.01% 1056
2025
Q2
Sell
-1,491
Closed -$224K 1161
2025
Q1
$224K Buy
1,491
+6
+0.4% +$1.01K ﹤0.01% 1012
2024
Q4
$274K Buy
1,485
+34
+2% +$6.55K ﹤0.01% 995
2024
Q3
$286K Buy
1,451
+1,044
+257% +$217K ﹤0.01% 962
2024
Q2
$84K Buy
407
+14
+4% +$3.17K 0.02% 445
2024
Q1
$106K Buy
393
+13
+3% +$3.1K 0.02% 411
2023
Q4
$90K Buy
380
+15
+4% +$2.95K 0.02% 428
2023
Q3
$72K Buy
365
+21
+6% +$4.31K 0.02% 421
2023
Q2
$72K Buy
344
+74
+27% +$14.7K 0.02% 428
2023
Q1
$54K Buy
270
+54
+25% +$12.2K 0.01% 452
2022
Q4
$47K Sell
216
-81
-27% -$17.7K 0.01% 423
2022
Q3
$58K Buy
297
+33
+13% +$7.12K 0.02% 405
2022
Q2
$56K Buy
264
+32
+14% +$7.82K 0.02% 418
2022
Q1
$66K Buy
232
+115
+98% +$35.5K 0.02% 424
2021
Q4
$44K Buy
117
+6
+5% +$2.33K 0.01% 430
2021
Q3
$46K Hold
111
0.03% 315
2021
Q2
$41K Buy
+111
New +$37.1K 0.03% 285

Other funds holding CRL

Benjamin Edwards Inc's CRL Position: Q4 2025 in Review

Benjamin Edwards Inc sold out of Charles River Laboratories (CRL) in Q4 2025, closing a stake of 2,211 shares — an estimated $346K sold.

Benjamin Edwards Inc first reported a position in CRL in Q2 2021 and held it in 17 quarters. The position peaked at $346K in Q3 2025. 582 funds tracked by Wall St. Rank hold CRL as of Q4 2025.

  • Benjamin Edwards Inc reported no remaining Charles River Laboratories position as of Q4 2025 after selling out during the quarter.
  • Benjamin Edwards Inc sold 2,211 Charles River Laboratories shares in Q4 2025, an estimated $346K.
  • Benjamin Edwards Inc first reported a position in Charles River Laboratories in Q2 2021 and held it in 17 quarters.
  • Benjamin Edwards Inc's Charles River Laboratories position peaked at $346K in Q3 2025.
  • 582 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2025.

Based on Benjamin Edwards Inc's 13F filing for Q4 2025, filed 2 Feb 2026.